Key result
Midlife obesity linked to ~70% greater odds of late-life amyloid positivity.
Why the study?
Obesity has differential associations with brain health across the life course, but most studies only use BMI rather than fat distribution measures to examine risk.
Does midlife or late-life obesity increase the odds of late-life brain amyloid deposition in adults without dementia?
Population
803 dementia-free participants in the ARIC study
Comparison
Midlife and late-life obesity measures (BMI, WC, WHR) vs non-obese measures
Design
Prospective cohort study
Follow-up
From 1987-1989 to 2011-2025
Authors
Loading...
Supports targeting midlife obesity for amyloid prevention; challenges late-life focus and leaves open causal confirmation in trials.
Does midlife or late-life obesity increase the odds of late-life brain amyloid deposition in adults without dementia?
Midlife obesity, but not late-life obesity, is significantly associated with increased odds of late-life brain amyloid deposition, highlighting midlife as a critical period for future brain health.
Dong et al. (2026) studied this question. Midlife obesity (BMI >= 30) was associated with a 70% increased odds of late-life amyloid positivity, while late-life obesity showed no such association.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: